Lista de obras -

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis

artículo científico publicado en 2017

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis

artículo científico publicado en 2017

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility ⬇️

artículo científico publicado en 2015

Arterial lesions in giant cell arteritis: A longitudinal study

artículo científico publicado en 2018

Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America

scientific article published on 03 October 2019

Efficacy of leflunomide in the treatment of vasculitis

scientific article published on 10 November 2020

Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis

scientific article published on 01 September 2019

Evaluation of damage in giant cell arteritis

artículo científico publicado en 2017

Experience With Direct-to-Patient Recruitment for Enrollment Into a Clinical Trial in a Rare Disease: A Web-Based Study.

artículo científico publicado en 2017

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System (PROMIS) in Systemic Vasculitis

artículo científico publicado en 2019

Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group

artículo científico publicado en 2017

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

artículo científico publicado en 2016

Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome-Wide Association Study

artículo científico publicado en 2015

Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

scientific article published on 03 December 2020

IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

artículo científico publicado en 2017

Patient-reported outcomes in Takayasu's arteritis.

artículo científico publicado en 2017

Patterns of Arterial Disease in Takayasu's Arteritis and Giant Cell Arteritis

artículo científico publicado en 2019

Patterns of clinical presentation in Takayasu's arteritis

artículo científico publicado en 2020

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

scientific article published on 24 June 2020

Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis

artículo científico publicado en 2018

Sequence-based screening of patients with idiopathic polyarteritis nodosa, granulomatosis with polyangiitis, and microscopic polyangiitis for deleterious genetic variants in ADA2

artículo científico publicado en 2020

Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma

artículo científico publicado en 2019

Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis

artículo científico publicado en 2018

Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis

artículo científico publicado en 2019

Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures

artículo científico publicado en 2015

Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis

artículo científico publicado en 2020

Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature

artículo científico publicado en 2015

Lista de obras de

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility ⬇️

Arterial lesions in giant cell arteritis: A longitudinal study

Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America

Efficacy of leflunomide in the treatment of vasculitis

Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis

Evaluation of damage in giant cell arteritis

Experience With Direct-to-Patient Recruitment for Enrollment Into a Clinical Trial in a Rare Disease: A Web-Based Study.

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System (PROMIS) in Systemic Vasculitis

Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome-Wide Association Study

Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Patient-reported outcomes in Takayasu's arteritis.

Patterns of Arterial Disease in Takayasu's Arteritis and Giant Cell Arteritis

Patterns of clinical presentation in Takayasu's arteritis

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis

Sequence-based screening of patients with idiopathic polyarteritis nodosa, granulomatosis with polyangiitis, and microscopic polyangiitis for deleterious genetic variants in ADA2

Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma

Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis

Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis

Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures

Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis

Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature